- Home
- KRKR vs AYTU Comparison
KRKR vs AYTU Comparison
Compare KRKR & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRKR
- AYTU
- Stock Information
- Founded
- KRKR 2010
- AYTU N/A
- Country
- KRKR China
- AYTU United States
- Employees
- KRKR N/A
- AYTU N/A
- Industry
- KRKR Business Services
- AYTU Biotechnology: Pharmaceutical Preparations
- Sector
- KRKR Consumer Discretionary
- AYTU Health Care
- Exchange
- KRKR Nasdaq
- AYTU Nasdaq
- Market Cap
- KRKR 8.5M
- AYTU 8.3M
- IPO Year
- KRKR 2019
- AYTU N/A
- Fundamental
- Price
- KRKR $5.51
- AYTU $1.21
- Analyst Decision
- KRKR
- AYTU
- Analyst Count
- KRKR 0
- AYTU 0
- Target Price
- KRKR N/A
- AYTU N/A
- AVG Volume (30 Days)
- KRKR 13.8K
- AYTU 25.9K
- Earning Date
- KRKR 03-11-2025
- AYTU 05-14-2025
- Dividend Yield
- KRKR N/A
- AYTU N/A
- EPS Growth
- KRKR N/A
- AYTU N/A
- EPS
- KRKR N/A
- AYTU N/A
- Revenue
- KRKR $31,657,328.00
- AYTU $77,232,000.00
- Revenue This Year
- KRKR $182.55
- AYTU N/A
- Revenue Next Year
- KRKR N/A
- AYTU $8.14
- P/E Ratio
- KRKR N/A
- AYTU N/A
- Revenue Growth
- KRKR N/A
- AYTU N/A
- 52 Week Low
- KRKR $2.76
- AYTU $0.95
- 52 Week High
- KRKR $12.99
- AYTU $3.45
- Technical
- Relative Strength Index (RSI)
- KRKR 72.70
- AYTU 54.07
- Support Level
- KRKR $5.30
- AYTU $1.04
- Resistance Level
- KRKR $5.60
- AYTU $1.39
- Average True Range (ATR)
- KRKR 0.34
- AYTU 0.11
- MACD
- KRKR 0.13
- AYTU 0.02
- Stochastic Oscillator
- KRKR 87.44
- AYTU 47.55
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.